On June 25, 2025, the Confederation of Indian Industry (CII), Telangana will hold a day-long conference, ‘Pillars of Protection – Forging a Safer Future for Pharma and Chemical Manufacturing’ in Hyderabad...
Building on the strong momentum of Mounjaro’s rollout in India, Eli Lilly has reported encouraging clinical trial results for its oral anti-obesity drug, Orforglipron. The new once-daily pill, part of the same GLP-1 drug class as Mounjaro and Zepboun
Following its prior report on the clinical success of Mounjaro, Eli Lilly has confirmed a considerable commercial response for the drug in India - the need for effective obesity and diabetes treatment is...
In a HIV prevention milestone, the US Food and Drug Administration (FDA) has approved Gilead Sciences' lenacapavir, a twice-a-year long-acting injection, for adults and adolescents at risk of HIV infection.
The Discovery Park Startup Showcase took centre stage at the London Biotechnology Show 2025, sparking dynamic conversations and real-time feedback between emerging biotech entrepreneurs and seasoned investors.
Natco Pharma announced on Thursday that it received a Form 483 from the United States Food and Drug Administration (USFDA) with seven observations following an inspection of its pharmaceutical division in Hyderabad...
With the updated Schedule M guidelines representing significant compliance issues for small and medium pharmaceutical units, the Mysuru pharma industry has taken a joint initiative to try and prepare for it...
Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not reimburse the cost of Alzheimer's drug Kisunla, blocking access for patients seeking treatment under the country...
.jpeg "Abbott, MSD Partner to Boost Diabetes Drug Distribution Nationwide")
In a significant move that intended to improve access diabetes care in India, global pharmaceutical leaders Abbott and MSD Pharmaceuticals have entered into a strategic partnership
Glenmark Pharmaceuticals announced on Wednesday that the US FDA issued a Form 483 with five procedural observations after an inspection of its Monroe Manufacturing Facility in North Carolina...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")